Surgery Partners Inc
$ 14.31
2.21%
20 Apr - close price
- Market Cap 1,811,878,000 USD
- Current Price $ 14.31
- High / Low $ 14.34 / 13.89
- Stock P/E N/A
- Book Value 13.37
- EPS -0.61
- Next Earning Report 2026-05-11
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.04 %
- ROE 0.03 %
- 52 Week High 24.18
- 52 Week Low 11.41
About
Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company is headquartered in Brentwood, Tennessee.
Analyst Target Price
$18.80
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-03-02 | 2025-11-10 | 2025-08-05 | 2025-05-05 | 2025-02-24 | 2024-11-12 | 2024-08-06 | 2024-05-07 | 2024-02-26 | 2023-11-07 | 2023-08-01 | 2023-05-01 |
| Reported EPS | 0.12 | 0.13 | -0.02 | 0.04 | 0.44 | -0.2512 | 0.21 | 0.1 | 0.44 | 0.19 | 0.28 | 0.08 |
| Estimated EPS | 0.3038 | 0.21 | 0.16 | 0.07 | 0.3769 | 0.25 | 0.2 | 0.07 | 0.38 | 0.16 | 0.08 | 0.01 |
| Surprise | -0.1838 | -0.08 | -0.18 | -0.03 | 0.0631 | -0.5012 | 0.01 | 0.03 | 0.06 | 0.03 | 0.2 | 0.07 |
| Surprise Percentage | -60.5003% | -38.0952% | -112.5% | -42.8571% | 16.7418% | -200.48% | 5% | 42.8571% | 15.7895% | 18.75% | 250% | 700% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-05-11 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | -0.17 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: SGRY
2026-04-19 04:08:35
Benchmark has reiterated its Buy recommendation for Surgery Partners (SGRY). The article doesn't provide further details on why Benchmark maintains this rating, as only the title and a placeholder content "MSN" were given.
2026-04-18 10:39:58
Surgery Partners (NASDAQ:SGRY) is set to release its Q1 2026 earnings, a critical report following a challenging Q4 2025 marked by unexpected headwinds and margin compression despite revenue growth. Investors will be looking for signs of recovery in same-facility revenues and case volume, as well as management's strategies to navigate industry pressures like labor costs and high debt, while continuing its growth-by-acquisition model. The report will assess if recent challenges were temporary or indicate a more persistent trend for the short-stay surgical sector leader.
2026-04-17 20:10:20
Stocks for Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen saw increases after a global logistics and energy cost cooling, indicated by the reopening of the Strait of Hormuz. Lower oil prices directly reduce operating and shipping costs for healthcare providers and medical device manufacturers, improving their profit margins. This "risk-on" sentiment also benefits high-growth biotech and pharmaceutical companies, as reduced market volatility encourages investment in R&D and clinical trials, with the global economy stabilizing an upward trend for elective procedures and pharmaceutical demand.
2026-04-17 20:09:50
Several healthcare and biotech stocks, including Envista, Baxter, Surgery Partners, Charles River Laboratories, and Repligen, observed a jump in their stock prices. This surge is attributed to the reopening of the Strait of Hormuz, which is expected to lower global logistics and energy costs, benefiting the healthcare sector by reducing operational and shipping expenses. Additionally, a resulting "risk-on" sentiment is driving investment back into high-growth biotech and pharmaceutical companies, fostering a more positive outlook for the sector's earnings and R&D.
2026-04-17 19:09:50
Surgery Partners, Inc. (NASDAQ: SGRY) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The company will host a conference call at 8:30 a.m. (Eastern Time) on the same day to discuss the results. Interested parties can access the call via phone or a simultaneous webcast on the company's Investor Relations website.
2026-04-17 19:09:50
Surgery Partners (NASDAQ:SGRY) announced it will release its first quarter 2026 results before market open on Tuesday, May 5, 2026, followed by a conference call and webcast at 8:30 a.m. ET. The company has provided dial-in numbers and replay details, noting that financial and material information is routinely posted on its investor relations website. This announcement aligns with Surgery Partners' consistent communication cadence for investor engagement.
